Pharmaceuticals: The Effectiveness and Efficiency of Alternative Promotional Strategies

REFERENCES

• Hensley S. Sorry, Doc, no dinners-to-go—Drug sales reps begin building a new marketing playbook. Wall Street J (Eastern Edition). 2002 April 23:D4.
   Google Scholar
• Anon. Physician survey slams sales reps, hints at need for budget reallocation. Med Marketing Media. 2003; 38(7):16.
   Google Scholar
• Jung P. No free lunch. Health Aff 2002; 21(2):226.
   Google Scholar
• Romano M. Inappropriate gifts warning? Mod Healthcare. 2002; 32(5):22.
   Google Scholar
• Adams C. FDA inundated trying to assess drug ad pitches. Wall Street J (East-ern Edition). 2002 March 14:B 1.
   Google Scholar
• Brass EP. Changing the status of drugs from prescription to over-the-counter availability. N Engl J Med. 2001; 345:810–16.
   PubMed Web of Science ®Google Scholar
• Shapiro JP, Schultz S. Prescriptions: How your doctor makes the choice. US News World Rep. 2001; 130(7):58–61.
   PubMedGoogle Scholar
• Pinto MB. On the nature and properties of appeals used in direct-to-consumer advertising of prescription drugs. Psychol Rep. 2000; 86:597–607.
   PubMed Web of Science ®Google Scholar
• McLean C. The real drug pushers. Newmagazine (Alberta Edition). 2001; 28(6):38–42.
   Google Scholar
• Handlin A, Mosca JB, Forgione DA, et al. Direct-to-consumer pharmaceutical advertising: The debate's not over. J Consumer Marketing. 2003; 20(2&3):227–37.
   Google Scholar
• Lipman MM. Should you take health advice from drug ads? Consumer Rep Health. 2000; 12(10):11.
   Google Scholar
• Tsai AC. Policies to regulate gifts to physicians from industry. JAMA. 2003; 290:1776.
   PubMedGoogle Scholar
• Benitez T. A primary concern. Incentive. 2003; 177(2):18–21.
   Google Scholar
• Nucifora A. Promotional products are more than just party favors. Long Island Bus News. 1998; 45(52):4c.
   Google Scholar
• Promotional Products Association International. The 2002 estimate of promo-tional products: Distributor sales. www.ppai.org/MediaInformation/IndustryStatistics/ SalesVolumeEstimates.
   Google Scholar
• Weeks WB, Wallace AE, Surott K. The changing face of pharmaceutical adver-tising. Marketing Health Serv. 2001; 21(3):27–30.
   PubMedGoogle Scholar
• Pinto MB, Pinto JK, Barber JC. The impact of pharmaceutical direct advertis-ing: Opportunities and obstructions. Health Marketing Q. 1998; 15(4):89–101.
   Google Scholar
• Borzo G. Consumer drug ads booming. FDA reviews restrictions. Am Med News. 1997; 40(6):37–8.
   Google Scholar
• Romano M. Ethical quandary. Mod Healthcare. 2002; 31(14):4–6.
   Google Scholar
• Huang AJ. The rise of direct-to-consumer advertising of prescription drugs in the United States. JAMA. 2000; 284:2240.
   PubMed Web of Science ®Google Scholar
• Findlay S. Do ads really drive pharmaceutical sales? Marketing Health Serv. 2002; 22(1):20–5.
   PubMedGoogle Scholar
• Optas, Inc., and DTC Perspectives. DTC Industry Check-Up. December 2003. www.optas.com/industrysurvey2003.pdf.
   Google Scholar
• Liebman M. The toughest task in marketing. Med Marketing Media. 2003; (Jan):67–75.
   Google Scholar
• Flynn LT, Alper PR. Does "direct-to-consumer" advertising of prescription drugs benefit the public's health? Health Priorities. 1999; 11(4). www.acsh.org/ healthissues/newsID.669/healthis sue_detail. asp.
   Google Scholar
• Mossinghoff GJ. Pharmaceutical manufacturers and self-regulation of drug ad-vertising and promotion. J Drug Issues. 1992; 22(2):235–44.
   Web of Science ®Google Scholar
• Vinod HD, Rao PM. R&D and promotion in pharmaceuticals: A conceptual framework and empirical exploration. J Marketing Theory Pract. 2000; 8(4):10–20.
   Google Scholar
• Dukes DE, Rogers JF, Paine EA. What you should know about direct-to-con-sumer advertising of prescription drugs. Defense Counsel J. 2001; 68(1):36–49.
   Google Scholar
• Rosenberg J. Patient orders: When patients ask for specific drugs.amednews.com. 2001 March 19. www.ama-assn.org/amednews/2001/03/19/hlsa0319. htm.
   Google Scholar
• Silversides A. Direct-to-consumer prescription drug ads getting bolder. CMAJ. 2001; 165:462.
   PubMed Web of Science ®Google Scholar
• Lipsky MS, Taylor CA. The opinions and experiences of family physicians re-garding direct-to-consumer advertising. J Fam Pract. 1997; 45:495–9.
   PubMed Web of Science ®Google Scholar
• Lewis C. The impact of direct-to-consumer advertising. FDA Consumer Maga-zine. 2003; (Mar/Apr). www.fda.govfidac/features/2003/203_dtc.html.
   Google Scholar
• Daly E. Advertising impact: Using the power of promotional gifts. Am Sales-man. 1993; 38(10):16–21.
   Google Scholar
• Gibb F. To give or not to give? Sales Marketing Manage. 1994: 146(9):136–9.
   Google Scholar
• Rudick J. Are you treating your customers like a one-night stand? Am Salesman. 1995; 40(2):23–7.
   Google Scholar
• Strout E. Doctoring sales. Sales Marketing Manage. 2001; 153(5):53–60.
   Google Scholar
• Waud DR. Pharmaceutical promotions-A free lunch? N Engl J Med. 1992; 327:351-3.
   Google Scholar
• Sibbald B. Doctors asked to take pledge to shun drug company freebies. CMAJ. 2001; 164:531.
   Web of Science ®Google Scholar
• Moynihan R. Who pays for the pizza? Redefining the relationships between doctors and drug companies. BMJ. 2003; 326:1189–92.
   PubMed Web of Science ®Google Scholar
• Agovinao T. Drug companies overstep boundaries. Marketing News. 2002; 36(17):17.
   Google Scholar
• Labson MS. The PhRMA code: A new roadmap for industry-physician interac-tions. Virtual Mentor. 2003; 5(7). www.ama-assn.org/ama/pub/category/print/10628. html.
   Google Scholar
• Robeznieks A. OIG issues drug marketing guidelines. amednews.com. 2002 Oct 21. www. ama-as sn. org/amednews/2002/10/2 1/prsa1021.htm.
   Google Scholar